Past Tuesday Talks — Exploring Culture and Diversity in BioPharma

Tuesday, October 3, 2023

Presented by Seema Kumar, CEO, Cure

We sat down with CEO & Co-Founder Maria Luisa Pineda, Ph.D. of Envisagenics to discuss how Maria brings her passion of culture and diversity to the NYC biopharma community.

Tuesday Talks with Maria Luisa Pineda, Ph.D. of Envisagenics

When: Tuesday, October 3, 5:30 P.M. Virtually
Where: Virtually on LinkedIn Live

Topic: A fireside chat about culture and diversity in BioPharma

Speakers: Maria Luisa Pineda, Ph.D., CEO & Co-Founder of Envisagenics. Moderated by Seema Kumar, CEO of Cure

Featured Speakers

Maria Luisa Pineda

About Maria Luisa Pineda, Ph.D.

Dr. Maria Luisa Pineda started as a high school Intel International Science Fair winner. For her undergraduate studies, Dr. Pineda was awarded an endowment of $2 million dollars from the Goizueta Foundation and an NIH fellowship with the Minority Access to Research Careers (MARC U*STAR) program. Dr. Pineda received her Doctorate from the prestigious Cold Spring Harbor Laboratory School of Biological Sciences as an Arnold and Mabel Beckman graduate student and a William Randolph Hearst foundation scholar. After graduating, she acquired investment experience in technology and life-sciences startup companies at Canrock Ventures and Golden Seeds, LLC. Under her leadership, Envisagenics has received non-dilutive SBIR grants from the National Institutes of Health, raised capital from investors, won several prestigious artificial intelligence competitions, and formed multiple research collaboration partnerships with Biopharma.

Seema Kumar

About Seema Kumar

Seema joined Cure Experience in 2022 as the Chief Executive Officer. Prior to Cure, Ms. Kumar spent nearly 20 years at Johnson & Johnson in senior leadership roles, including most recently as the Global Head, Office of Innovation, Global Health and Scientific Engagement, and served on J&J’s Innovation Strategy, Public health leadership and the COVID-19 vaccine steering committee, where she led the company’s external affairs efforts and public education program on COVID and vaccine literacy. Before her tenure at J&J, Ms. Kumar was the Chief of Staff to Dr. Eric Lander and the Chief Communications Officer at the Whitehead Institute/Massachusetts Institute of Technology Center for Genome Research where she played a leadership role in the Human Genome Project. She also has held leadership positions at the U.S. National Institutes of Allergy and Infectious Diseases (NIAID), the National Institutes of Health, and Johns Hopkins School of Medicine. Ms. Kumar holds an M.S. in Science Journalism and Communications from the University of Maryland.